The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Apolipoprotein E: Structure-Function Relationships
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified Gly145Asp and Arg154Cys in the same J o u r n a l P r e -p r o o f region (amino acids ~ 148 to 168) [47]”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Variants predicted by models to be deleterious or being located near or in the receptor binding region (amino acids ~ 148 to 168) [47] could be suspected to pose ε2-like qualities.”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Additional support comes from the present data, where Gly145Asp and Arg154Cys are located in the receptor binding region (amino acids ≈148 to 168) 28 and display a phenotype similar to the ɛ2‐defining Arg176Cys residue with high apoE levels and seemingly low risk of dementia (no events).”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“Val254Glu and Arg269Gly are located in the lipid‐binding carboxyl‐terminal domain (amino acids ≈243 to 317). 28 , 42”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“However, the receptor-binding sites (AA136-150) for lipoprotein receptors such as the low-density lipoprotein receptor (LDLR), lipoprotein-related receptor 1 (LRP1), and heparan sulfate proteoglycans (HSPGs) are located in a region conserved between species (Fig. 1a) [11–14].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“Notably, an HSPG and LDLR binding site in the APOE sequence is conserved in mice (blue boxed area, AA136-150), including arginine 136, which is replaced by serine in the Christchurch (Ch) variant [12, 39].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“However, mAPOE and hAPOE have a conserved LDLR and HSPG binding motif between AA136 to 150 (human numbering) [11, 12, 39], which includes the R136S Christchurch variant.”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“The mature apoE protein consists of 299 amino acids and an 18amino acid signal peptide is removed post-translationally [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The APOE gene is located on chromosome 19 and consists of four exons [28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Lipid-free apoE consists of two domains connected by a “hinge region”: the amino-terminal domain (amino acids 1 to 191) contains the receptor-binding function and the carboxyl-terminal domain (~amino acids 225 to 299) contains the lipid-binding function [28,33].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The low density lipoprotein (LDL) receptor binding region is situated in helix four between amino acids 136 and 150 [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE2 exhibits a lower affinity to the LDL receptor compared to apoE3: ~1% of the binding activity of apoE3 and apoE4 [28,36].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Furthermore, apoE and apoB share the sequence with highest affinity for arterial proteoglycans, a key phenomenon for lipoprotein deposition in the arterial wall [28,63].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE contains two independently folded functional domains; these are a 22-kDa N-terminal domain (residues 1–191) and a 10-kDa C-terminal domain (residues 216–299) linked by a hinge region (18, 19).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [18]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Prediction of protein conformation
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a002 · Cited by 3,309
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Research works printed but not linked: 17
- Cassel, 1984, Atherosclerosis (Shannon, Irel.), 52, 203
- Hallman, 1991, Am. J. Hum. Genet., 49, 338
- Havel, 1989, 1, 1129
- Koizumi, 1985, Antherosclerosis (Shannon, Irel.), 58, 175
- Landis, 1987, Am. J. Physiol., 252, G805
- Lund-Katz, 1993, J. Biol. Chem.
- Mahley, 1983, Arch. Pathol. Lab. Med., 107, 393
- Mahley, 1989, 1, 1195
- Mahley, 1983, 4, 151
- Mahley, 1977, Am. J. Pathol., 87, 205
- Mahley, 1983, Biochim. Biophys. Acta., 737, 197, 10.1016/0304-4157(83)90001-1 · DOI
- Mahley, 1989, 1, 1195
- Phillips, 1986, 128, 387
- Srinivasan, 1972, Atherosclerosis (Shannon, Irel.), 16, 95
- Utermann, 1980, Am. J. Hum. Genet., 32, 339
- Weisgraber, 1983, 4, 103
- Yamamura, 1984, Atherosclerosis (Shannon, Irel.), 50, 159
Cited by
Sorted by citations
Items 701–800 of 828
Ahmed, M. U., & Akhteruzzaman, S. (2006) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2006.203.208 · Cited by 2
The neuronal functions of human apolipoprotein E
Ong, Q., & Wong, B. (2013) · OA Biochemistry · doi:10.13172/2052-9651-1-1-442 · Cited by 2
Preeprem, T., & Gibson, G. C. (2013) · BioData Mining · doi:10.1186/1756-0381-6-24 · Cited by 2
The Amyloid _-Protein and Alzheimer's Disease
Teplow, D. B., Yang, M., Roychaudhuri, R., Pang, E. S., Huynh, T. V., Chen, M., & Beroukhim, S. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-2 · Cited by 2
Species, Strain, and Gender Issues in the Development and Validation of Animal Models of Dementia
Dijck, A. V., Dam, D. V., & Deyn, P. P. D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_4 · Cited by 2
Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Questions
Andrés, B. C., Muñoz-Calvo, M. T., Calero, O., Aparicio, C., Argente, J., & Calero, M. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3894-6 · Cited by 2
Isolation of recombinant apolipoprotein E4 N-terminal domain by foam fractionation
Lethcoe, K., Fox, C. A., Hafiane, A., Kiss, R. S., & Ryan, R. O. (2023) · Protein Expression and Purification · doi:10.1016/j.pep.2023.106319 · Cited by 2
Gene-environment interactions in considering physical activity for the prevention of dementia
Bates, K. A. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.3.359 · Cited by 2
Apolipoprotein M – Studies of Structure and Function
Ahnström, J. (2009) · Lund University Publications (Lund University) · Cited by 2
Protein corona critically affects the bio-behaviors of SARS-CoV-2Preprint
Yin, Y.-W., Sheng, Y.-J., Wang, M., Ni, S., Ding, H.-M., & Ma, Y. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2102.05440 · Cited by 4
Possible genetic factors related to hormone treatment effects
Hogervorst, E., Henderson, V. W., Gibbs, R. B., & Brinton, R. D. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511635700.016 · Cited by 2
Apolipoprotein-ε4 (APOE) Gene Is a Risk Factor for Human Coronary Artery Disease
Hazarika, L., & Sen, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_61-1 · Cited by 1
Mahley, R. W. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_2-1 · Cited by 1
Jeevanandam, J., & Saraswathi, N. T. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2584338 · Cited by 1
The Plasma Free Fatty Acid Carrier Proteome is Altered in Diet‐Induced and Genetically Obese Mice
Tomoo, K., Zhang, Y., Portalatin, A. Z. D., & Henderson, G. C. (2026) · Obesity · doi:10.1002/oby.70214 · Cited by 1
APOE, Inflammation, and T Cells in Translational Disease Models and Clinical Medicine
Adlimoghaddam, A., Cervantes, D., & Wheeler, C. J. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_35 · Cited by 1
[The scavenger receptor and its importance in amyloid processes].
Aguilar-Gaytán, R., & Mas‐Oliva, J. (2002) · PubMed · Cited by 1
Genetic Risk Factors: Their Function and Comorbidities in Alzheimer′s Disease
Hiltunen, M. O., Bertram, L., & Saunders, A. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/925362 · Cited by 1
Genes and Acute Neurologic Disease and Injury: A Primer for the Neurologic Intensive Care Nurse
Alexander, S. A., & Beach, M. (2008) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2008.01.001 · Cited by 1
Role of Apolipoprotein E in Alzheimer’s Disease: Clues from its Structure
Weisgraber, K. H., & Dong, L. (1996) · Springer eBooks · doi:10.1007/978-3-642-80109-9_2 · Cited by 1
Self-citationThe human apoE7 and apoE4 transgenic mice models
Sun, M., & Qi, Z. (2001) · Science in China Series C Life Sciences · doi:10.1007/bf02879360 · Cited by 1
APOE-Based Models of “Pre-Dementia”
Sullivan, P. M. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_22 · Cited by 1
The Metabolism of Apolipoprotein E and the Alzheimer's Diseases
Roses, A. D. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch16 · Cited by 1
Hazarika, L., Sen, S., & Doshi, J. (2022) · Computational Biology and Bioinformatics · doi:10.11648/j.cbb.20221002.11 · Cited by 1
ApoE, Human Fertility, and Reproduction
Fagla, B. M., Tai, L. M., & Buhimschi, I. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_67-1
Apolipoprotein E Polymorphism and Plasma Lipid Levels in Native Mongolian Sheep
Tsunoda, K., NOZAWA, K., MAEDA, Y., Tumennasan, K., Zhanchiv, T., Tanabe, Y., Shimizu, T., & Sato, K. (1999) · Biochemical Genetics · doi:10.1023/a:1018767512483 · Cited by 1
Apolipoprotein E4: A Risk Factor for Successful Cognitive Aging
Kwon, O. D. (2016) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2016.15.3.61 · Cited by 1
Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Answers
Andrés, B. C., Muñoz-Calvo, M. T., Calero, O., Aparicio, C., Argente, J., & Calero, M. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3919-1 · Cited by 1
Apolipoprotein E and Alzheimer’s Disease: Therapeutic Implications
Strittmatter, W. J., Huang, D. Y., Saunders, A. M., Schmechel, D. E., Pericak‐Vance, M. A., Roses, A. D., Weisgraber, K. H., & Goedert, M. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_11 · Cited by 1
Self-citationPotential Biological Mechanisms of ApoE in Alzheimer’s Disease
Rebeck, G. W. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_2 · Cited by 1
The Effects of Apolipoprotein E Genotype on Brain Lipid Metabolism
Tietz, A., Oron, L., Mazliah, E., & Michaelson, D. M. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_6 · Cited by 1
Divergent Metabolism of Apolipoproteins E3 and E4 by Cells
Pitas, R. E., Ji, Z.-S., Supeková, Ľ., & Mahley, R. W. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_4 · Cited by 1
Nikonov, A. (2014) · DSpace repository (University of Tartu) · Cited by 1
Fan, D., Korando, L., Dothager, R. S., Li, Q., & Wang, J. (2004) · Journal of Biomolecular NMR · doi:10.1023/b:jnmr.0000032517.98560.39 · Cited by 1
Heparan Sulfate in the Amyloidosis and Inflammation of Alzheimer’s Disease
O′Callaghan, P. W. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Structural Differences Between Apolipoprotein E3 and E4 as Measured by 19F- NMR
Garai, K., Mutafi, S. M., Baban, B. A., & Frieden, C. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.3577 · Cited by 2
Biochemical investigations in patients with dementia
Green, A. (2002) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563021902143 · Cited by 1
Apolipoprotein E: Structural and Functional Interactions with Amyloid β
Stine, W. B., & LaDu, M. J. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch10 · Cited by 1
Apolipoprotein Gene Structure and Function
Martín-Campos, J. M., Chang, B. H.-J., Blanco‐Vaca, F., Chan, L., & Julve, J. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0005909.pub3 · Cited by 1
Jolivalt, C. G., Leininger‐Muller, B., Bertrand, P., & Siest, G. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_6 · Cited by 1
Apolipoprotein Gene Structure and Function
Huey, P. U., & Chan, L. (2006) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0005909 · Cited by 1
Grandl, M. (2006) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.10433 · Cited by 1
Schmechel, D. E., Xu, P., Gilbert, J. R., & Roses, A. D. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4887-4_10 · Cited by 1
Koutseff, A. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
The Role of Apolipoprotein E Concentration and Isoform in Amyloid-beta Metabolism In Vivo
Castellano, J. M. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7416v3s
Gau, B. C. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k72r3pq8
Alexander, S. A. (2004) · D-Scholarship@Pitt (University of Pittsburgh)
Interactions of Apolipoprotein E with Microtubule-Associated Proteins
Strittmatter, W. J., de Serrano, V. S., Huang, D. Y., Martin, M. E., Roses, A. D., & Saunders, A. M. (1996) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-80109-9_12
Fotakis, P., Kardassis, D., & Zannis, V. I. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.34.suppl_1.584
Regulierung und Verfügbarkeit von Apolipoprotein E in Astrozyten
Hamker, U. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15272
Romero‐Moraleda, B. (2014) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.30454
Apolipoprotein E Oxidation Through Enzymes Localized into the Brain
Leininger‐Muller, B., Jolivalt, C. G., Herber, R., Bertrand, P., & Siest, G. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2907-8_7
Nakamura, K., Hara, S., Tanaka, T., Hoshii, Y., Yamada, M., Ishihara, T., & Nagasaka, Y. (1998) · SEIBUTSU BUTSURI KAGAKU · doi:10.2198/sbk.42.27
Oxidative modification of apolipoprotein E in very low density lipoprotein and its inhibition.
Arai, H., Nagasaka, Y., Kashiwagi, S., Furumoto, H., & Nakamura, K. (2000) · SEIBUTSU BUTSURI KAGAKU · doi:10.2198/sbk.44.271
A new variant of apolipoprotein E in a girl with lipoprotein glomerulopathy.
Ogawa, T., Arai, H., Watanabe, T., Kobayashi, Y., Morikawa, A., Maruyama, K., Hattori, H., & Egashira, T. (1998) · Japanese journal of pediatric nephrology · doi:10.3165/jjpn.11.171
Bibliography NIA/AlzA Conference on Apolipoprotein E Genotyping in Alzheimer's Disease
Kwon, Y. J., Tsai, J., & Relkin, N. R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32609.x
Genetic and Expressional Studies of Alzheimer's Disease
Iivonen, S. (2005)
Aufnahme, Abbau und Bindung von ApoE(3/3)- versus ApoE(4/4)-Liposomen in hippokampalen Zellen
Medizin, E., & Beisiegel†, U. (2004)
Fast Photochemical Oxidation of Proteins for Structural Characterization
Jones, L. M. (2013) · Springer eBooks · doi:10.1007/978-1-4419-7862-2_9
Rodriguez, G. A. (2014) · DigitalGeorgetown (Georgetown University Library)
Polvikoski, T. M. (2004) · Työväentutkimus Vuosikirja
Association of Apolipoprotein E Genotype with Early and Advanced Atherosclerotic Lesions
Ilveskoski, E. (2001) · Tampere University Institutional Repository (Tampere University)
Apolipoprotein E, hormone therapy, and neuroprotection
Struble, R. G., & McAsey, M. E. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511635700.018
Zellbiologie, M., Medizin, E., & Beisiegel†, U. (2005)
Cui, R., Yumei, W. A. N., Sun, J., Wang, J., Xu, P., & Sun, X. (2013) · Journal of Fishery Sciences of China · doi:10.3724/sp.j.1118.2012.00741
Kerr, M. E., DeKosky, S. T., Kay, A., & Marion, D. W. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1721-4_15
Sampedro, F. P. (2016) · TDX (Tesis Doctorals en Xarxa)
Jansen, D., Zerbi, V., Janssen, C. I. F., van Rooij, D., Dederen, P. J. W. C., Heerschap, A., & Broersen, L. M. (2013)
Will absence of GPAT1 improve diet-induced atherosclerosis in ApoE heterozygous mice?
Wu, P. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/s148-1p55
THAKUR, R. K. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i3.204
Differences in transcriptional responses to acute and chronic dietary interventions with fatty acids
Matualatupauw, J. C. (2017) · doi:10.18174/414660
Genes, Aging, and Parkinson’s Disease
Milanese, C., & Mastroberardino, P. G. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00389
Issa, M. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2018.tde-02022018-101833
Dwivedi, S., Madeshiya, A. K., Singh, S., Chandra, A., & Mahdi, A. A. (2018) · Meta Gene · doi:10.1016/j.mgene.2018.04.002
Castranio, E. L. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Badr, E. A. E., Safan, M. A., & Hadhoud, M. (2011) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2011.35979
孙明增, & 琦祖和 (2001) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2001-31-1-1
Conformational Reorganisation of Apolipoprotein E Triggered by Phospholipid AssemblyPreprint
Prakashchand, D. D., & Mondal, J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.255299
Apo D and Apo E Levels in Autism Spectrum DisordersPreprint
Esnafoğlu, E., & Cırrık, S. (2021) · Research Square · doi:10.21203/rs.3.rs-562010/v1
Rangel, B., & Milena, A. (2021)
Carrasquillo, M. M., Bu, G., & Nielsen, H. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_2
Pandit, S. (2022) · Biomolecular NMR Assignments · doi:10.1007/s12104-022-10078-3
Apolipoprotein Gene Structure and Function
Huey, P. U., Chang, B. H.-J., & Chan, L. (2007) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0005909.pub2
Biochemistry, C. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)80731-0
Narayanaswami, V., Reddick, I., Celis, G., Pal, S., Nguyen, J., Deepa, S., & Garai, K. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5158139
Reddick, I., Celis, G., Pal, S., Nguyen, J., Saraswathi, D., Garai, K., & Narayanaswami, V. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110421
Correas, Á. G., Stromsnes, K., Lupu, R. I., & González, G. O. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_29-1 · Cited by 1
Bovine Luteal Secretory Proteins of the Oestrous Cycle and Pregnancy
Fields, M. J., Ndikum-Moffor, F. M., Simmen, R. C. M., Buhi, W. C., Rollyson, K., Kowalski, A., Chang, S., & Fields, P. (1996) · Reproduction in Domestic Animals · doi:10.1111/j.1439-0531.1996.tb00005.x
Apolipoproteins and cardiovascular diseases
Kaur, A., Saha, S., Ujjainiya, R., Ray, A., Basak, T., & Sengupta, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00032-4
Di, C., Tang, T., Wu, H., Gan, J., Shi, Z., Yi, T., Chen, R., Liu, S., & Ji, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251393713
Zvintzou, E., Giannopoulou, P. C., Giannatou, K., Ioniță, R., Alemi, M., Kakafoni, G., Mparnia, V., Dumitrescu, M., Fenyo, I. M., Gafencu, A. V., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100958
Behavioral Aspects of Apolipoprotein E Knockout Mice
Litherland, M. T. (2003)
Olfactory Behavior in ApoE Knockout Mice
Yost, J. (2001) · Journal of Collective Bargaining in the Academy
Metadata
- Authors
- Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Weisgraber, Karl H.
- Venue
- Advances in Protein Chemistry
- Publisher
- Elsevier
- Published
- 1994
- Volume
- 45
- Pages
- 249-302
- ISSN
- 0065-3233 (ISSN-L)
- OpenAlex
- W98152484
- Cited by
- 830
- References
- 194
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 12 · 2021: 20 · 2020: 12 · 2019: 13 · 2018: 14 · 2017: 20 · 2016: 18 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 26
- FWCI
- 89.45
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in protein chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, lipoprotein metabolism, apolipoprotein structure, APOE isoforms, lipid transfer proteins, lipoprotein receptors, triglyceride-rich lipoproteins, reverse cholesterol transport, lipolysis, serum lipoproteins
- MeSH terms
- Amino Acid Sequence, Animals, Apolipoproteins E, Humans, Molecular Sequence Data, Protein Conformation, Structure-Activity Relationship, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
